COMPOSITION

We describe an antibody or antigen-binding fragment thereof comprising a heavy chain variable region (VH) sequence and a light chain variable region (VL) sequence of a clone selected from: 5C4, 4H1, 1D2, 1C4, 2B5, 1F1, 1H1, 4A5, 1D8, 1D3, 2F1, 3C6, 3D12, 3A9, 1F4, 1H10, 3C12, 4G11, 4A12, 1A12, 3G12,...

Full description

Saved in:
Bibliographic Details
Main Authors WANG, Cheng-I, LEE, Wen-Hsin, NGOH, Zi Xian Eve, HUANG, Ching-Wen, WANG, Bei, YEAP, Yee Chin, Yvonne
Format Patent
LanguageEnglish
French
German
Published 26.01.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

Abstract We describe an antibody or antigen-binding fragment thereof comprising a heavy chain variable region (VH) sequence and a light chain variable region (VL) sequence of a clone selected from: 5C4, 4H1, 1D2, 1C4, 2B5, 1F1, 1H1, 4A5, 1D8, 1D3, 2F1, 3C6, 3D12, 3A9, 1F4, 1H10, 3C12, 4G11, 4A12, 1A12, 3G12, 4F9, 4G4 and 1E1 which is capable of specifically binding to glypican-3 (GPC-3) (GenBank Accession Number: NP_004475.1), or a sequence having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence identity thereto.
AbstractList We describe an antibody or antigen-binding fragment thereof comprising a heavy chain variable region (VH) sequence and a light chain variable region (VL) sequence of a clone selected from: 5C4, 4H1, 1D2, 1C4, 2B5, 1F1, 1H1, 4A5, 1D8, 1D3, 2F1, 3C6, 3D12, 3A9, 1F4, 1H10, 3C12, 4G11, 4A12, 1A12, 3G12, 4F9, 4G4 and 1E1 which is capable of specifically binding to glypican-3 (GPC-3) (GenBank Accession Number: NP_004475.1), or a sequence having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence identity thereto.
Author YEAP, Yee Chin, Yvonne
WANG, Bei
NGOH, Zi Xian Eve
HUANG, Ching-Wen
WANG, Cheng-I
LEE, Wen-Hsin
Author_xml – fullname: WANG, Cheng-I
– fullname: LEE, Wen-Hsin
– fullname: NGOH, Zi Xian Eve
– fullname: HUANG, Ching-Wen
– fullname: WANG, Bei
– fullname: YEAP, Yee Chin, Yvonne
BookMark eNrjYmDJy89L5WTgdvb3DfAP9gzx9PfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGliaGliZGjkbGRCgBAAPDHa4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate COMPOSITION
ZUSAMMENSETZUNG
ExternalDocumentID EP3941942A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3941942A23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:36:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3941942A23
Notes Application Number: EP20200773383
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220126&DB=EPODOC&CC=EP&NR=3941942A2
ParticipantIDs epo_espacenet_EP3941942A2
PublicationCentury 2000
PublicationDate 20220126
PublicationDateYYYYMMDD 2022-01-26
PublicationDate_xml – month: 01
  year: 2022
  text: 20220126
  day: 26
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Agency for Science, Technology and Research
RelatedCompanies_xml – name: Agency for Science, Technology and Research
Score 3.3796282
Snippet We describe an antibody or antigen-binding fragment thereof comprising a heavy chain variable region (VH) sequence and a light chain variable region (VL)...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Title COMPOSITION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220126&DB=EPODOC&locale=&CC=EP&NR=3941942A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_G_H7S6nB-sQfpW3FLs7R9KOLSlil0LTplb6NJM9jLHLbiv-8ldNMXfQsXOHKB313uI3cAt4x45UBndX23VA4VxcAR0l84gjBfKlmqwsw6TCds_EqfZsNZC5abvzCmT-iXaY6IiJKI99ro6_VPECsytZXVnVgi6f0-mYaR3XjHBM0ZYXY0CuM8izJuc44re_IcugFFd508oLbewVe0p8EQv430p5T1b4uSHMNujsxW9Qm01MqCA74ZvGbBftrkuy3YMwWaskJiA8LqFI54lubZy6MOLp1BL4mnfOwg__lWlnmcb0_idqCNLr46hx4J-oJ6ZVD0PUXRAfH7hRcQxYakXFAi_S50_2Rz8c_eJRzqS9EhA8KuoF1_fKprNKK1uDHifwMdgnNV
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KfVRPGi3WZw-SWzDdbDfJIYjNg1SbBxqlt5DHFnqpxUT8-06WtHrR2zILw-7AN7Pz2BmAW0b0ctRkdQ2t5ArNs5GSF8ZCyQkzCl6UPBOzDoOQ-a_0cT6ed2C5-Qsj-oR-ieaIiKgC8V4Lfb3-CWI5orayusuXSHq_9xLLkVvvmKA5I0x2JpYbR05ky7aNKzl8tjSTortOHlBb7-ALW2_A4L5Nmk8p698WxTuC3RiZrepj6PCVBD17M3hNgv2gzXdLsCcKNIsKiS0IqxM4tKMgjl6mTXDpFIaem9i-gvzT7V1SN96eROtDF118fgZDYqo51UszU3VO0QEx1Ew3CWdjUi4oKYwBDP5kc_7P3g30_CSYpbNp-HQBB42AmvABYZfQrT8--RUa1Dq_FqL4BrBadkg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOSITION&rft.inventor=WANG%2C+Cheng-I&rft.inventor=LEE%2C+Wen-Hsin&rft.inventor=NGOH%2C+Zi+Xian+Eve&rft.inventor=HUANG%2C+Ching-Wen&rft.inventor=WANG%2C+Bei&rft.inventor=YEAP%2C+Yee+Chin%2C+Yvonne&rft.date=2022-01-26&rft.externalDBID=A2&rft.externalDocID=EP3941942A2